Donald W Nibbelink
age ~90
from Wilmington, DE
- Also known as:
-
- Elsie D Nibbelink
- Donal W Nibbelink
- Don W Nibbelink
- Donald W Nebbelink
- Donald W Nibbleink
- Elsie D Nibbleink
- Phone and address:
-
1 School Rd, Wilmington, DE 19803
302-655-9646
Donald Nibbelink Phones & Addresses
- 1 School Rd, Wilmington, DE 19803 • 302-655-9646 • 215-362-1419
- 17 Park Ave, Lansdale, PA 19446 • 215-362-1419
- 17 Park Dr, Lansdale, PA 19446 • 215-362-1419
Work
-
Position:Medical Professional
Education
-
Degree:Associate degree or higher
Us Patents
-
Controlled Release Combination Of Carbidopa/Levodopa
view source -
US Patent:49007556, Feb 13, 1990
-
Filed:Feb 24, 1989
-
Appl. No.:7/315057
-
Inventors:Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA -
Assignee:Merck & Co. - Rahway NJ
-
International Classification:A61K 920
A61K 922
A61K 926 -
US Classification:424469
-
Abstract:A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levidopa combinations presently employed.
-
Controlled Release Combination Of Carbidopa/Levodopa
view source -
US Patent:49834002, Jan 8, 1991
-
Filed:Dec 1, 1989
-
Appl. No.:7/444222
-
Inventors:Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA -
Assignee:Merck & Co., Inc. - Rahway NJ
-
International Classification:A61K 922
A61K 926
A61K 3178 -
US Classification:424469
-
Abstract:A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levodopa combination presently employed.
-
Controlled Release Combination Of Carbidopa/Levodopa
view source -
US Patent:48329576, May 23, 1989
-
Filed:Jul 25, 1988
-
Appl. No.:7/223861
-
Inventors:Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA -
Assignee:Merck & Co., Inc. - Rahway NJ
-
International Classification:A61K 920
A61K 922
A61K 926 -
US Classification:424469
-
Abstract:A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levodopa combinations presently employed.
Medicine Doctors
Donald Wilfred Nibbelink, Philadelphia PA
view sourceSpecialties:
Neurology
Psychiatry
Psychiatry
Work:
UPHS-Anesthesiology-Intensive
3400 Spruce St, Philadelphia, PA 19175
3400 Spruce St, Philadelphia, PA 19175
Education:
University of Iowa (1965)
License Records
Donald W Nibbelink
Address:
Lansdale, PA 19446
License #:
MD016333E - Expired
Category:
Medicine
Type:
Medical Physician and Surgeon
Youtube
Get Report for Donald W Nibbelink from Wilmington, DE, age ~90